Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Other financing activities (2019 - 2025)

Biodesix (BDSX) has disclosed Other financing activities for 7 consecutive years, with $418000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other financing activities rose 122.34% year-over-year to $418000.0, compared with a TTM value of $30000.0 through Dec 2025, up 106.74%, and an annual FY2025 reading of $30000.0, up 106.74% over the prior year.
  • Other financing activities was $418000.0 for Q3 2025 at Biodesix, up from -$399000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $3.6 million in Q4 2022 and bottomed at -$1.0 million in Q4 2023.
  • Average Other financing activities over 5 years is $199263.2, with a median of $1000.0 recorded in 2021.
  • The sharpest move saw Other financing activities crashed 1000.0% in 2022, then soared 18700.0% in 2024.
  • Year by year, Other financing activities stood at $568000.0 in 2021, then soared by 533.1% to $3.6 million in 2022, then tumbled by 128.39% to -$1.0 million in 2023, then surged by 52.69% to -$483000.0 in 2024, then soared by 186.54% to $418000.0 in 2025.
  • Business Quant data shows Other financing activities for BDSX at $418000.0 in Q3 2025, -$399000.0 in Q2 2025, and $11000.0 in Q1 2025.